Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy  by Hellings, Willem E. et al.
Gender-associated differences in plaque phenotype
of patients undergoing carotid endarterectomy
Willem E. Hellings, MD,a,b Gerard Pasterkamp, MD, PhD,b Bart A. N. Verhoeven, MD, PhD,a
Dominique P. V. De Kleijn, PhD,b Jean-Paul P. M. De Vries, MD, PhD,c Kees A. Seldenrijk, MD, PhD,d
Theo van den Broek, MD,b and Frans L. Moll, MD, PhD,a Utrecht and Nieuwegein, The Netherlands
Background: Carotid endarterectomy to prevent a stroke is less beneficial for women compared with men. This benefit is
lower in asymptomatic women compared with asymptomatic men or symptomatic patients. A possible explanation for
this gender-associated difference in outcome could be found in the atherosclerotic carotid plaque phenotype. We
hypothesize that women, especially asymptomatic women, have more stable plaques than men, resulting in a decreased
benefit of surgical plaque removal.
Methods:Carotid endarterectomy specimens of 450 consecutive patients (135 women, 315men) were studied. The culprit
lesions were semi-quantitatively analyzed for the presence of macrophages, smooth muscle cells, collagen, calcifications,
and luminal thrombus. Plaques were categorized in three phenotypes according to overall presentation and the amount
of fat. Protein was isolated from the plaques for determination of interleukin-6 (IL-6) and IL-8 concentrations and
matrix metalloproteinase-8 (MMP-8) and MMP-9 activities.
Results: Atheromatous plaques (>40% fat) were less frequently observed in women than in men (22% vs 40%; P < .001).
In addition, plaques obtained from womenmore frequently revealed lowmacrophage staining (11% vs 18%; P .05) and
strong smooth muscle cell staining (38% vs 24%; P  .001). Compared with men, women had a lower plaque
concentration of IL-8 (P  .001) and lower MMP-8 activity (P  .01). The observed differences were most pronounced
in asymptomatic women, who showed themost stable plaques, with an atheromatous plaque in only 9% of cases compared
with 39% in asymptomatic men (P .02). In addition, a large proportion of plaques obtained from asymptomatic women
showed high smooth muscle cell content (53% vs 30%; P  .03) and high collagen content (55% vs 24%; P  .003). All
relations between gender and plaque characteristics, except for MMP-8, remained intact in a multivariate analysis,
including clinical presentation and other cardiovascular risk factors.
Conclusion:Carotid artery plaques obtained fromwomen have a more stable, less inflammatory phenotype compared with
men, independent of clinical presentation and cardiovascular risk profile. Asymptomatic women demonstrate the highest
prevalence of stable plaques. These findings could explain why women benefit less from carotid endarterectomy compared
with men. (J Vasc Surg 2007;45:289-97.)Carotid endarterectomy (CEA) reduces the risk of
stroke in both symptomatic and asymptomatic patients
with high-grade carotid artery stenosis. The benefit of the
operation in terms of stroke reduction differs among pa-
tient subgroups. Gender is a major determinant of the
long-term outcome after carotid surgery.
It has been well established that CEA is more beneficial
for men than for women. Carotid plaque associated stroke
risk in patients on best medical treatment is higher in men
than in women. After carotid surgery, stroke risk is reduced
to comparable levels for both sexes, resulting in a larger
reduction of stroke risk in men.1-3 This gender difference in
outcome after CEA is evident in symptomatic and asymp-
tomatic patients. Randomized trials suggest that although
asymptomatic women still benefit from CEA, their benefit
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doi:10.1016/j.jvs.2006.09.047is smaller compared with asymptomatic men or symptom-
atic patients.1-2,4
Our understanding of these gender differences is in-
complete. Different hypotheses have been raised that might
account for the observed differences in outcome after ca-
rotid endarterectomy between men and women. Duplex
analyses of the carotid artery before surgery have demon-
strated that plaque volume is larger in men than in women
at a comparable stenosis grade and that the plaque size is a
predictor of clinical outcome.5 Effects of hormones on
atherosclerosis are becoming better known with increasing
research,6 but no direct pathophysiologic link has been
recognized between hormones and outcome of carotid
surgery.
The observed clinical differences may also be a direct
reflection of carotid plaque characteristics. If women have
plaques that are less prone to cause a stroke owing to distal
embolization, then removal of such a plaque would be less
beneficial. In coronary circulation, certain plaque charac-
teristics are strongly associated with unstable clinical pre-
sentation. The vulnerable plaque that gives rise to myocar-
dial infarction or unstable angina is defined as a plaque with
high fat content, low structural components (thin fibrous cap,
low smooth muscle cell and collagen content), high inflam-
matory cell content, and increased protease activity. 7-9
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shown that the pathophysiology of carotid artery disease is
very similar to coronary artery disease. The vulnerable
plaque characteristics known from coronary circulation
have been linked to symptomatic presentation of carotid
artery disease.10-12 In addition, the association between
plaque destabilization and matrix metalloproteinase-8
(MMP-8) andMMP-9 activity in carotid artery plaques has
been reported.13,14
In this study we hypothesized that women who have
been diagnosed with hemodynamically significant athero-
sclerotic carotid artery disease have more stable carotid
plaques than men and that this is especially evident in
women who are asymptomatic. This could explain the
observation that CEA is less beneficial in women.
PATIENTS AND METHODS
Athero-Express biobank. The Athero-Express is an
ongoing longitudinal biobank study with the objective of
studying the relation between plaque characteristics and
the occurrence of future cardiovascular events.15 All pa-
tients undergoing CEA in two participating Dutch hospi-
tals are asked to participate in the study, with an inclusion
rate of 94.6%. At baseline, patients complete an extensive
questionnaire and blood is drawn and stored at –80°C.
During CEA, the plaque is transferred to the laboratory
and processed and stored according to a standardized pro-
tocol. After surgery, patients undergo duplex and clinical
follow-up. The Medical Ethical Committees of the partic-
ipating hospitals have approved the study, and all patients
provided written informed consent. For the purpose of the
current research question, we studied all consecutive pa-
tients undergoing CEA who were included in the Athero-
Express study between April 2002 and November 2005.
Patient inclusion and preoperative work-up. The
indication for CEA was based on the recommendations pub-
lished by the Asymptomatic Carotid Surgery Trial (ACST) for
asymptomatic patients and European Carotid Surgery Trial
(ECST)/North American Symptomatic Carotid Endarter-
ectomy Trial for symptomatic patients (NASCET).2,16-18
All patients were examined by a neurologist for assessment
of their preoperative neurologic status. The percentage of
stenosis was determined with duplex ultrasonography, us-
ing duplex criteria as described by Strandness et al.19,20 If
the duplex investigation was not conclusive, an additional
imaging technique (magnetic resonance angiography,
computed tomography angiography, conventional angiog-
raphy) was used to determine the level of carotid stenosis.
Excluded were patients with a terminal malignancy and
those who were referred back to a hospital outside The
Netherlands immediately after surgery.
Baseline characteristics. Baseline data were obtained
by chart review and from extensive questionnaires completed
by the participating patients that included questions on his-
tory of cardiovascular disease, cardiovascular risk factors
(smoking, hypertension, diabetes), and use of medication.
Presenting symptoms and duplex stenosis were retrieved from
patient charts. Symptom categories were asymptomatic, de-fined as no carotid territory ischemic symptoms; amaurosis
fugax, defined as ipsilateral mono-ocular blindness of acute
onset lasting 24 hours; cerebral transient ischemic attack
(TIA), defined as ipsilateral focal neurologic deficit of acute
onset lasting 24 hours; and ipsilateral stroke. Lipid spectra
were determined in blood specimens drawn at baseline.
Carotid endarterectomy. CEA was performed under
general anesthesia. Patients received 5000 IU heparin in-
travenously before cross-clamping. All endarterectomies
were performed by an open, noneversion technique, with
careful dissection of the bifurcation into the internal and
external carotid arteries. The atherosclerotic plaque was
immediately transferred to the laboratory after removal.
Plaque processing. The atherosclerotic plaque was
dissected into 5-mm segments by a dedicated technician.
The segment having the greatest plaque area was defined as
the culprit lesion. This segment was fixated in formalde-
hyde 4%, decalcified for 1 week in ethylenediaminetetraace-
tic acid, and embedded in paraffin. The other segments
were snap frozen in liquid nitrogen and stored at –80°C.
Sections of 5-m thickness were cut on a microtome for
immunohistochemical staining.
Plaques were characterized for macrophage content
(CD68 staining), smooth muscle cell content (-actin
staining), collagen content (picrosirius red), and extent of
calcification (hematoxylin and eosin [H&E] staining) and
were analyzed semi-quantitatively and scored as no, minor,
moderate, and heavy staining, as reported previously.15
Briefly, no and minor represent absent or minimal staining
with few clustered cells, whereasmoderate and heavy repre-
sent larger areas of positive staining. Presence of luminal
thrombus (H&E and elastin van Gieson staining) was
scored as absent or present. The percentage of atheroma of
the total area of the plaque was visually estimated using the
picrosirius red and H&E stains. Three overall phenotypes
were considered according to overall presentation and vi-
sual estimation of the percentage of atheroma in the
plaques: fibrous plaques containing 10% fat, fibroathero-
matous, 10% to 40%; or atheromatous, 40% fat.
The scorings were done by observers blinded for
patient characteristics. In addition, quantitative mea-
surements were performed for macrophage and smooth
muscle cell staining. For this purpose, images of plaque
cross-sections were recorded onto a computer worksta-
tion using a microscope equipped with a digital camera.
The images were captured and analyzed with AnalySIS
3.2 software (Soft Imaging System GmbH, Münster,
Germany). The quantification was done as follows: in
each plaque, three representative areas were defined and
selected in such a way that no media (which was present
in the specimen, in most cases) was included. The posi-
tive staining in these areas was measured as a percentage
of total plaque area using AnalySIS software. The mean
of these three measurements was used for further analysis.
Interleukin and matrix metalloproteinase measure-
ments. The segment adjacent to the culprit lesion was used
for protein isolation. This frozen segment was mechanically
crushed in liquid nitrogen with a pestle and mortar. The
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pure reagent (Boehringer Mannheim, Germany), accord-
ing to the manufacturer’s protocol and (2) by dissolving in
40 mM Tris-HCl (pH, 7.5) at 4°C.
Protein from 301 plaques was available for analysis.
Interleukin-6 (IL-6) and IL-8 concentrations were deter-
mined in all samples. The measurements were done on the
Tris-solated samples using a multiplex suspension array
system according to the manufacturer’s protocol (Bio-Rad
Laboratories, Hercules, Calif). MMP-8 and MMP-9 activ-
ities were measured for a randomly selected group of 133
patients in Tripure isolated protein using Biotrak activity
assays RPN 2635 and RPN 2634, respectively (Amersham
Biosciences, Buckinghamshire, UK). MMP activities were
expressed as an arbitrary unit. All measurements were done
by investigators blinded for patient characteristics.
Data analysis. The statistical software SPSS 11.5
(SPSS Inc, Chicago, Ill) was used for data analysis. Contin-
uous baseline variables are given as mean and standard
deviation. All plaque measurements are expressed as me-
dian and interquartile range. Equal distribution of baseline
variables was determined using the 2 test for discrete
variables, the Student’s t test for normally distributed con-
tinuous variables and the Mann Whitney U test for
nonnormally distributed continuous variables. The Mann
Whitney U test was used for comparison of plaque stain-
ings, IL, and MMP levels between men and women and
between combined groups according to gender and symp-
tom status. The association between gender and plaque
characteristics was adjusted for traditional cardiovascular
risk factors, clinical presentation, and all baseline variables
showing an association (P  .20) with gender, using mul-
tivariate logistic regression. For this purpose ordinal vari-
ables were dichotomized into two categories (no/minor
staining vs moderate/heavy staining) and continuous vari-
ables were dichotomized at the median. Values of P  .05
were considered statistically significant.
RESULTS
A total of 450 carotid plaques were obtained. The
baseline characteristics are given in Table I. Clinical presen-
tation was equal for men and women: 25% of women and
22% of men were asymptomatic. Women (n  135) had
higher total cholesterol, accompanied by a higher low-
density-lipoprotein cholesterol as well as higher high-den-
sity-lipoprotein cholesterol. Use of 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) reductase inhibitors
(statins), aspirin, and oral anticoagulants did not differ
between men and women. The other baseline characteris-
tics, including duplex stenosis, were also comparable.
The plaques obtained from women demonstrated a
more fibrous phenotype compared with those obtained
from men. Atheromatous plaques were present in 22% of
women compared with 40% of men (P  .001; Table II). In
38% of women, a heavy smooth muscle cell staining was
present, compared with 24% in men (P  .001). Heavy
macrophage staining was found in 14% of women com-
pared with 21% in men (P  .05). Luminal thrombus,calcifications, and collagen staining did not differ consis-
tently between men and women. Assessment of lipid spec-
tra in relation to overall plaque phenotype did not reveal
any associations (data not shown).
Plaque characteristics were compared between men
and women within the symptom groups (asymptomatic vs
TIA/stroke). This analysis shows that differences in plaque
characteristics were comparable or even more evident in
asymptomatic male and female patients (Fig). Plaque over-
all phenotype was more atheromatous in asymptomatic
men than in asymptomatic women. Atheromatous plaques
were found in 9% of asymptomatic women compared with
39% of asymptomatic men (P .02) and 44% of symptom-
atic men (P  .001). This difference was also evident but
less prominent when symptomatic women were compared
with symptomatic men (27% vs 44%; P  .003).
Smooth muscle cell staining also revealed strong differ-
ences within the asymptomatic group. High staining for
smooth muscle cells was observed in 53% of asymptomatic
women compared with 30% of asymptomatic men (P 
.03) and 20% of symptomaticmen (P .001).High collagen
staining was present in 53% of asymptomatic women com-
Table I. Baseline characteristics of patients undergoing
carotid endarterectomy
Variable*
Women,
n (%)
Men,
n (%) P
Patients (n) 135 315
Age (year) 66.2  9.3 67.7  8.5 .09
Hypertension 100 (74) 211 (67) .15
Diabetes 30 (22) 62 (20) .53
Prior intervention
Vascular 41 (30) 128 (41) .04†
Ipsilateral carotid 9 (7) 11 (4) .14
Smoking 41 (31) 76 (25) .20
Hypercholesterolemia 68 (62) 156 (62) .96
HRT 6 (7)
Statins 79 (66) 182 (63) .58
Aspirin 106 (85) 249 (85) .90
Oral anticoagulation 17 (14) 48 (16) .46
NSAID 8 (6) 12 (4) .32
Cholesterol, mmol/L 5.4  1.1 4.9  1.2 .006†
HDL, mmol/L 1.3  0.36 1.1  0.35 .004†
LDL, mmol/L 3.2  1.0 2.9  1.0 .04†
Triglycerides, mmol/L 2.1  1.2 2.1  1.0 .96
Symptoms
Asymptomatic 33 (25) 69 (22)
Amaurosis fugax 18 (13) 45 (14) .91
TIA 47 (35) 118 (38)
Stroke 37 (27) 83 (26)
Duplex stenosis
50% to 64% 3 (2) 9 (3)
65% to 89% 46 (36) 112 (37) .84
90% to 100% 79 (62) 181 (60)
HRT, Hormone replacement therapy; NSAID, nonsteroidal anti-
inflammatory drug; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; TIA, transient ischemic attack.
*Categoric variables are presented as n (%); continuous variables as mean 
standard deviation.
†Statistically significant (P  .05).pared with 22% of asymptomatic men (P .003) and 15% of
vascul
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collagen staining was observed in the symptomatic patient
group. Macrophage staining was not significantly different
between men and women within the asymptomatic or
symptomatic patient group.
The differences in plaque histology between men and
women were paralleled by the inflammatory and protease
activity in atherosclerotic plaques (Table III). Women
showed lower values of the proinflammatory cytokine IL-8
compared with men (25.9 vs 51.3 pg/mL; P  .001).
Levels of proinflammatory cytokine IL-6 were not different
between men and women. Protease activity was lower in
women, with MMP-8 showing significantly lower values
than in men (4.2 vs 7.1; P .01), whereas MMP-9 activity
was lower without reaching statistical significance (1.6 vs
2.6; P  .07). These differences were still present when
men and women were subdivided into symptomatic and
asymptomatic groups (Table IV). Asymptomatic women
showed lower levels of interleukins and MMPs compared
with the other groups: IL-8 levels (14.1 vs 83.3 pg/mL;
Table II. Comparison of carotid plaque histology betwee
Women* (%)
Overall phenotype (semi-quantitative)
Fibrous 40.7
Fibroatheromatous 37.8
Atheromatous 21.5
Luminal thrombus
No 77.0
Yes 23.0
Macrophages (semi-quantitative)
No 18
Minor 31.6
Moderate 36.8
Heavy 13.5
Macrophages (quantitative)
Median area % 0.26
IQR (0.08-0.95)
SMC (semi-quantitative)
No 0.8
Minor 20.3
Moderate 41.4
Heavy 37.6
SMC (quantitative)
Median area % 2.27
IQR (0.86-4.35)
Collagen (semi-quantitative)
No 0.0
Minor 19.4
Moderate 53.0
Heavy 27.6
Calcifications (semi-quantitative)
No 29.6
Minor 15.6
Moderate 28.9
Heavy 25.9
SMC, Smooth muscle cells; IQR, interquartile range.
*Data presented as percentage or median (IQR), as noted.
†Adjusted for symptom status, age, hypertension, diabetes, smoking, prior
‡Statistically significant (P  .05).P  .001), MMP-8 activity (2.6 vs 9.2; P  .003), andMMP-9 activity (1.1 vs 2.9; P  .002) were significantly
decreased compared with symptomatic men.
All associations between gender and plaque phenotype,
except MMP-8, which were significant in univariate analy-
sis, were also significant when adjusting for symptom sta-
tus, age, hypertension, diabetes, smoking, prior vascular
intervention, prior ipsilateral carotid intervention, and cho-
lesterol levels. This suggests that the observed gender-
associated differences in plaque characteristics are not
caused by differences in cardiovascular risk factors or clini-
cal presentation.
DISCUSSION
The main finding of this study is that women undergo-
ing CEA have more stable plaques compared with men.
Plaques obtained from women contain less fat and macro-
phages and more smooth muscle cells. This is accompanied
by lower IL-8 content and lower MMP-8 activity.
It has been recognized that histologic plaque charac-
teristics are related to the clinical presentation of athero-
n and women
Men* (%) P (univariate) P (multivariate)†
.001‡ .006‡
24.4
35.2
40.3
.26 .45
70.6
29.4
.05† .20
10.6
33.2
35.2
21
.12 .36
0.39
(0.07-1.30)
.001‡ .01‡
1.9
32.9
41.9
24.2
.03‡ .03‡
1.62
(0.47-3.58)
.08 .39
0.3
22.6
57.6
19.4
.41 .88
25.7
24.8
31.1
18.4
ar intervention, prior ipsilateral carotid intervention, and cholesterol levels.n mesclerotic coronary and carotid artery disease. To our knowl-
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Fig. Comparison of carotid plaque histology between men and women, subdivided by symptom status: asymptomatic
vs transient ischemic attack/stroke (TIA). A, Plaque overall phenotype. B, Luminal thrombus. C, Macrophages. D,
Smooth muscle cells. E, Collagen. F, Calcification. *P  .05.
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carotid plaque phenotype, probably because of the number
of patients required. In coronary artery disease, gender-
associated differences in plaque morphology have been
described that point to a higher prevalence of fresh throm-
bus and plaque rupture in men.21,22 These studies did not,
however, specifically address gender-related differences in
plaque phenotype but focused on changes in plaque mor-
phology in relation to clinical syndromes like acute myo-
cardial infarction or coronary death.
Our present study indicates that women operated on
for carotid artery disease show more stable atherosclerotic
plaques than men. These results suggest that not just
plaque volume but also plaque phenotype may be associ-
ated with adverse outcomes. Iemolo et al5 found that
outward remodeling of the carotid artery was more evident
in men than in women. This outward remodeling was
predictive of stroke and other cardiovascular events. Out-
ward remodeling has previously been associated with un-
stable plaque characteristics, rendering the results from
Iemolo et al very consistent with ours.23
IL-8 was significantly higher in men compared with
women, but IL-6 showed no statistically significant differ-
ence. Most reduced levels of both cytokines were observed
in the asymptomatic women. Both proinflammatory cyto-
kines can be produced by a variety of cells within the
atherosclerotic plaque and play an important role in athero-
sclerosis.24 It remains to be elucidated whether a differen-
tial effect exists between IL-6 and IL-8, which could ex-
plain the fact that IL-8 has a stronger relation to gender and
plaque instability than IL-6.
In the current study, women showed significantly lower
MMP-8 activity in their plaques than did men. MMP-9 was
lower in asymptomatic women compared with symptom-
Table III. Interleukin and matrix metalloproteinase
measurements in the plaque compared between men
and women
Women Men
P
(univariate)
P
(multivariate)*
IL-6 .2 .89
Median 6.7 8.8
IQR 0.5-21.1 3.6-19.3
IL-8 .001† .01†
Median 25.9 51.3
IQR 0-59.3 8.8-147.4
MMP-8 .01† .34
Median 4.2 7.1
IQR 1.2-8.1 3.7-11.4
MMP-9 .07 .42
Median 1.6 2.6
IQR 0.9-3.1 0.8-6.4
IL, Interleukin; IQR, interquartile range; MMP, matrix metalloproteinase.
*Adjusted for symptom status, age, hypertension, diabetes, smoking, prior
vascular intervention, prior ipsilateral carotid intervention, and cholesterol
levels.
†Statistically significant (P  .05).atic men. Experimental models and previous human end-arterectomy series have shown that the presence of these
MMPs contributes to plaque instability.13,14 MMPs are
important in cell migration, degradation of the fibrous cap,
expansive remodeling, and intraplaque neovessel forma-
tion.25 Their production can be directly inhibited by st-
atins.26
To our knowledge, no gender differences in MMP
activity have been described in human atherosclerotic dis-
ease before. Two studies on rat aortas show higher MMP-9
production in male rat aortas compared with females,
which could be partially reversed by estrogen treatment or
transplantation of the artery into a female rat.27,28 This
suggests that there may be a direct effect of sex hormones
on MMP production contributing to attenuation of ath-
erosclerotic disease in females. It is difficult to extrapolate
these findings to our population because most of the
women in our study cohort are postmenopausal. The ob-
served differences in plaque phenotype could be due to
estrogen exposure earlier in life resulting in a more stable
plaque phenotype with inherent lower MMP-8 and
MMP-9 activity compared with unstable plaques.
The gender-related differences we observed in plaque
histology, inflammation, and protease activity were evident
within all symptom categories. Therefore, the gender dif-
ferences cannot merely be explained by different clinical
presentation of the carotid artery disease; neither can they
be attributed to differences in cardiovascular risk profiles,
because all associations between gender and plaque charac-
teristics, except MMP-8, remained intact when correcting
for cardiovascular risk factors. The differences are most
pronounced in the asymptomatic group: Among asymp-
tomatic women, the prevalence of stable plaques is very
high. Although speculative, one of the reasons for the large
differences within the asymptomatic group compared with
the symptomatic group is that when a plaque becomes
symptomatic, some features have already changed, both in
men and women. The asymptomatic group probably better
represents the true gender-associated differences in plaque
phenotype. Nevertheless, we also found gender-associated
differences in the symptomatic patient group.
The more prevalent stable plaque phenotype found in
women may explain why CEA is less effective in preventing
a stroke in women. In all randomized, controlled trials of
CEA, women have a lower baseline risk of stroke compared
with men that is reduced to an equal level for both sexes
after surgery. Thus, women benefit less from CEA then
men.1,2,16-18,29 Asymptomatic women benefit the least
from CEA, as shown in the ACST and Asymptomatic
Carotid Atherosclerosis Study trials.1,2,4 Stable, fibrous
plaques are less prone to cause ischemic events in the
coronary and the carotid arteries.7-12
Our observations led us to hypothesize that removal of
a stable plaque is less beneficial than removal of a vulnerable
plaque, which is more frequently found in asymptomatic
men and symptomatic patients. In addition, the aforemen-
tioned studies showed that women have a slightly higher
perioperative risk than men, also contributing to gender
differences in benefit of CEA. Interestingly, the presence of
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microembolization during CEA.30
Our results suggest that selecting patients for CEA on
the basis of plaque characteristics may hold a promise for
the future. This is especially true for patient groups with a
small margin of benefit from the operation. We show that
variations in plaque phenotype that exist within different
patient groups are consistent with previously reported out-
comes after CEA. Selection of asymptomatic women for
CEAwho have vulnerable, unstable plaques might improve
the long-term outcome. High-risk groups that benefit
greatly from CEA, such as symptomatic men with high-
grade stenosis, would probably benefit to a lesser extent
from such a strategy. The new imaging techniques such as
high-resolution magnetic resonance imaging, single pho-
ton emission computed tomography, and palpography may
bring the potential of the observed differences in plaque
level into clinical practice.31-33
Limitations. In the current study, we examined the
segment with the largest plaque area and not the entire
plaque. The rationale for this method is that the segment of
the plaque with the largest plaque burden is the part with
the most inflammation and the largest atheroma.23 It has
also been shown that assessment of the culprit segment is
reasonably representative for the plaque as a whole.34 In
some cases, an important feature might be missed when
only the culprit lesion is studied, potentially masking dif-
ferences between groups. This drawback is overcome by the
large number of patients in our study.
CONCLUSION
Women undergoing CEA have more stable carotid
plaques than men, with lower fat, lower macrophage and
higher smooth muscle cell content, and lower inflamma-
tory and protease activity. This is not explained by clin-
ical presentation and cardiovascular risk factors, suggest-
ing an independent gender-related effect on carotid
plaque phenotype of patients undergoing carotid endar-
Table IV. Interleukin and matrix metalloproteinase measu
subdivided by symptom status
1
Asymptomatic women
2
Asymptomatic Men Sym
IL-6
Median 6.3 7.9
IQR 1.6-23.4 3.6-12.0
IL-8
Median 14.1 17.2
IQR 0-31.6 0.5-53.6
MMP-8
Median 2.6 5.0
IQR 0-6.6 2.5-8.5
MMP-9
Median 1.1 1.4
IQR 0.3-2.7 0.4-3.6
IL, Interleukin; IQR, interquartile range; MMP, matrix metalloproteinase.
*Statistically significant (P  .05).terectomy. The gender-associated differences in plaquephenotype are most evident in asymptomatic women,
which could explain why especially asymptomatic women
have lower long-term stroke reduction after carotid endar-
terectomy.
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How many of you consider gender when deciding whether
carotid endarterectomy (CEA) might be appropriate in patients
with asymptomatic carotid disease? Chances are, relatively few!
Yet, the Asymptomatic Carotid Atherosclerosis Study (ACAS)
showed no conclusive evidence that surgery conferred benefit in
women, and once perioperative strokes were included, neither did
the Asymptomatic Carotid Surgery Trial (ACST). When the data
from the two trials are combined, the gender differences are
difficult to ignore.1
Two observations from the trials might explain why women
gained less benefit. First, women had a lower natural history of
stroke risk than men. Second, women incurred higher morbidityvascular operations. Accordingly, the overall benefit fromCEAwill
be diminished. So should all asymptomatic women now be denied
surgery? Definitely not!
It is, however, becoming untenable to simply treat all asymp-
tomatic men and women as if they derived equivalent benefit.
Combined ACAS and ACST data1 indicate that CEA conferred a
twofold reduction in stroke in men (odds ratio, 2.0; 95% confi-
dence interval, 1.5 to 2.8) compared with neutral benefit in
women (OR 1.04; 95% confidence interval, 0.7 to 1.6). However,
because the confidence intervals straddle “1,” there is still a degree
of statistical uncertainty. It is inevitable, therefore, that certain
womenwill gain considerable benefit from surgery, but can they be
identified?
